Cell-Free Protein Synthesis for Rapid Metabolic Pathway Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Metabolic engineering is costly and time-consuming due to the complexity of cell membranes and the need for extensive design-build-test cycles, particularly in optimizing biosynthetic pathways for chemical production, such as n-butanol, which requires balancing fluxes and regulating transcription, translation, and genome modifications.
Innovation Solution
The development of cell-free protein synthesis driven metabolic engineering (CFPS-ME) systems that allow for the modular assembly of lysates containing enzyme components produced by overexpression or cell-free protein synthesis, enabling rapid prototyping and optimization of biosynthetic pathways by bypassing in vivo limitations and reducing the need for cloning steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional metabolic engineering methods are used to optimize biosynthetic pathways, then the pathways can be regulated and optimized, but the process becomes costly and time-consuming due to extensive design-build-test cycles
Solution Approach 1:
The patent extracts the metabolic pathway enzymes from living cells and places them in a cell-free system. This extraction eliminates the need for complex cellular machinery, genome modifications, and extensive DBT cycles while maintaining pathway regulation capability. The cell-free system allows direct manipulation of enzyme components without the constraints of cellular membranes and metabolic networks.
Solution Approach 2:
The patent creates a simplified copy of the metabolic pathway in a cell-free environment that replicates the essential functions of the original in vivo system without the complexity of living cells. This copying approach allows rapid prototyping and optimization of biosynthetic pathways using purified enzymes and controlled reaction conditions.
2Reliability
If cell membranes are used to contain metabolic pathways, then the pathways can be regulated, but the complexity of cell membranes and the need for balancing fluxes makes the process difficult and time-consuming
Solution Approach 1:
The patent removes the pathway from the complex cellular environment and places it in a simplified cell-free system. This extraction eliminates cell membranes, organelles, and the need to balance cellular fluxes while retaining the ability to regulate pathway activity through controlled enzyme addition and substrate provision.
Solution Approach 2:
The patent changes the physical and chemical parameters of the system by moving from in vivo to in vitro conditions. This allows independent control of enzyme concentrations, substrate availability, and reaction conditions without the constraints of cellular homeostasis and membrane transport limitations.
3Manufacturing precision
If extensive genome engineering and transcription-translation regulation are performed, then pathway optimization is achieved, but the number of design-build-test cycles increases, increasing cost and time
Solution Approach 1:
The patent extracts the biosynthetic pathway from the complex process of genome engineering and cellular regulation. By using a cell-free system with purified enzymes, the patent eliminates the need for genome modifications, transcription factor engineering, and translation optimization while achieving the same pathway optimization goals.
Solution Approach 2:
The patent replaces the biological machinery of genome engineering, transcription, and translation with a simpler biochemical system using purified enzymes. This substitution eliminates the need for complex genetic manipulations and allows direct control of pathway flux through enzyme addition and substrate provision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
CFPS-ME significantly accelerates the design-build-test cycles by allowing for the rapid construction and optimization of biosynthetic pathways, increasing the resolution of enzyme kinetics and metabolic flux studies, and enhancing the control over pathway performance, leading to higher yields and reduced production costs.
Implementation Method 1
providing a transcription template, a polymerase, ATP, GTP, CTP, and UTP to prepare the translation template
Implementation Method 2
expressing the translation template in the protein reaction vessel to prepare an enzyme
Implementation Method 3
the feedstock reacts in the presence of the enzyme to prepare the chemical product
Implementation Method 4
the cellular extract provides natural enzyme metabolism from the host strain... provides energy; provides cofactor regeneration
Data Source
AI summary
Disclosed are cell-free systems for metabolic engineering, methods for cell-free metabolic engineering, kits for preparing the disclosed systems, and kits for performing the disclosed methods. The disclosed systems, methods, and kits may be utilized to prepare a chemical product and to optimize conditions for preparing a chemical product. The disclosed systems, methods, and kits also may be utilized for combinatorial cell-free metabolism engineering.